New program aims to help seniors master glucose monitors
NCT ID NCT05337826
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a remote education program called REST, designed to help adults aged 65 and older with insulin-treated diabetes start and keep using continuous glucose monitors (CGMs). The goal is to reduce dangerous low blood sugar episodes and improve overall glucose control. Researchers will also look at what helps or hinders CGM use in this age group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous Glucose Monitor (device) and remote education program (REST model)
What this could lead to
If successful, this could provide a practical, patient-centered model to help older adults with diabetes use continuous glucose monitors more effectively, reducing dangerous low blood sugar episodes.
What could go wrong
This is a relatively small study (122 participants) focused on feasibility and education, not a large-scale efficacy trial. Results may not apply to all older adults, and the program may not be widely adopted outside of research settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States